Sign in

Julian Ventres, PharmD BCPS

@jjventres.bsky.social
2.3K followers 2.3K following 122 posts

Clinical pharmacist interested in infectious disease, antimicrobial resistance, and optimizing PK/PD targets Also an avid birder and photographer

PostsRepliesMedia
Julian Ventres, PharmD BCPS @jjventres.bsky.social · 11/12/2025
Treatment options for recurrent NDM-Pseudomonas bacteremia 2/2 UTI? Resistant to all the normal things. Previously treated with cefiderocol with MIC of 4, colistin MIC of 2. Aztreonam/avibactam an option here? Any luck getting FEP + taniborbactam or nacubactam? #IDSky
100
Reposted by Julian Ventres, PharmD BCPS
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 19/10/2025
🆕🔥🔥CloCeBa RCT Cloxacillin versus cefazolin for MSSA Bacteraemia Cefazolin has a non-inferior efficacy regarding mortality, microbiological or clinical endpoints and was associated with a lower rate of serious adverse events #IDSky www.thelancet.com/journals/lan...
04016
Reposted by Julian Ventres, PharmD BCPS
josh farkas 💊 @pulmcrit.bsky.social · 24/07/2025
we're under-utilizing aminoglycosides for urosepsis in patients with good renal function rising % ESBL is pushing us to use carbapenems for empiric therapy... leading to more resistance (CDiff, CRE) aminoglycosides have minimal gut penetration = low CDiff risk & protect microbiome 🧵 #1/4 #EMIMCC
53812
Julian Ventres, PharmD BCPS @jjventres.bsky.social · 19/06/2025
Looking for people that have unrestricted linezolid at their institutions. Any increases in resistance? Better to just ease up on use criteria? Currently reviewing our own usage and seeing what we can do with rising tetracycline resistance in S. aureus #IDSky #AMSky
130
Julian Ventres, PharmD BCPS @jjventres.bsky.social · 30/05/2025
Linezolid for odontogenic infections? Anyone doing this empirically? It feels like the data is there that LZD covers the relevant bugs, but there's no clinical data that I could find. Have to think LZD would be preferable to clinda #IDSky #AMSky
110
Reposted by Julian Ventres, PharmD BCPS
Contagion® @contagionlive.bsky.social · 20/05/2025
Innoviva Specialty Therapeutics’ antibiotic is the first and only FDA-approved cephalosporin indicated to treat Staphylococcus aureus bacteremia, including right-sided endocarditis, caused by the methicillin-resistant Staphylococcus aureus. #IDsky #Medsky
contagionlive.com
Ceftobiprole Launches Commercially in US
Innoviva Specialty Therapeutics’ antibiotic is the first and only FDA-approved cephalosporin indicated to treat Staphylococcus aureus bacteremia (SAB), including right-sided endocarditis, caused by th...
062
Reposted by Julian Ventres, PharmD BCPS
BITSCOPIC @bitscopic.bsky.social · 05/05/2025
Derived from the PEN-FAST allergy decision tool, the CEPH-FAST version was developed and validated in this study. www.journalofinfection.com/article/S016...   #IDsky #pharmsky
journalofinfection.com
Development and Validation of a Cephalosporin Allergy Clinical Decision Rule
Utilising the previously published and internationally validated tool PEN-FAST, we validated the same criteria with minor modifications for low-risk cephalosporin allergies. The results suggest that a...
175
Reposted by Julian Ventres, PharmD BCPS
Erin McCreary, PharmD @erinmccreary.bsky.social · 12/04/2025
@steventong.bsky.social presents the results of the PSSA domain of the SNAP 🫰 trial - the worlds largest trial of staph aureus bacteremia - at #ESCMID2025 fluclox resulted in higher mortality and more AKI compared to penicillin for PSSA
27633
Reposted by Julian Ventres, PharmD BCPS
Bug Pharmacist // Tim Gauthier @idstewardship.bsky.social · 26/03/2025
📝Here are my cliff notes for the recently FDA approved drug #gepotidacin #blujepa www.idstewardship.com/drugs/gepoti... 🤔 Still wondering where the name comes from? It’s a yellow tablet… Kind of sounds like Jet Blue 🤷‍♂️ Anything to add? #IDsky
1176
Julian Ventres, PharmD BCPS @jjventres.bsky.social · 08/03/2025
If your institution has a Clinical Decision Unit for intermediate patients who may or may not need inpatient care, do they primarily use IV or PO antibiotics? Trying to push for more PO in this setting but also trying to anticipate challenges #IDSky #Pharmsky
020
Reposted by Julian Ventres, PharmD BCPS
Betsy Hirsch, PharmD (TLOAS) @ebhirsch.bsky.social · 20/02/2025
‼️The @idsainfo.bsky.social cUTI guideline 📄 draft is now available for public comment🗣️! This version has been reviewed by 15+ orgs & revised according to extensive feedback provided to us. www.idsociety.org/practice-gui... UTIsky IDsky Medsky PharmSky
Screenshot of IDSA cUTI guideline open for public commentDraft of IDSA cUTI guideline showing steps to follow for selection of therapy Figure 2 flowchart showing stepwise assessment of IV to PO switch and duration of therapyFigure showing old vs new definition of uUTI, cUTi, and acute pyelonephritis
54422
Reposted by Julian Ventres, PharmD BCPS
ASHE Journal @ashejournal.bsky.social · 17/02/2025
An inpatient antimicrobial stewardship team driven penicillin allergy delabeling protocol for minimal and low-risk penicillin allergic patients #IDsky bit.ly/3EDPPOP
bit.ly
An inpatient antimicrobial stewardship team driven penicillin allergy delabeling protocol for minimal and low-risk penicillin allergic patients | Antimicrobial Stewardship & Healthcare Epidemiolog...
An inpatient antimicrobial stewardship team driven penicillin allergy delabeling protocol for minimal and low-risk penicillin allergic patients - Volume 5 Issue 1
043
Julian Ventres, PharmD BCPS @jjventres.bsky.social · 10/02/2025
#IDSky preferred approach to recurrent MDR Pseudomonas? Respiratory isolate, currently on ceftazidime monotherapy. Susceptible only to tobramycin. Avycaz, Zerbaxa and Recarbio sensis not done yet but previously resistant. @bradspellberg.bsky.social @dralicehan.bsky.social @idiots-pod.bsky.social
330
Reposted by Julian Ventres, PharmD BCPS
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 07/02/2025
Breaking news🔥 US FDA approves EMBLAVEO (aztreonam and avibactam) for complicated intra-abdominal infections (cIAI) in adult patients who have limited or no alternative options #idsky
1289
Julian Ventres, PharmD BCPS @jjventres.bsky.social · 01/02/2025
Reading through some IV vs Oral endocarditis papers and loved this excerpt from Heldman 1996, "we felt that we could not ethically require orally treated subjects to undergo the central venous catheter insertion and maintenance...only to deliver intravenous vehicle without active drug" #IDSky
090
Reposted by Julian Ventres, PharmD BCPS
Nico Cortés-Penfield MD @cortes-penfield.bsky.social · 08/01/2025
All of human medicine rests on Streptomyces being kind of a dick neighbor
0103
Julian Ventres, PharmD BCPS @jjventres.bsky.social · 29/12/2024
Does your institution dose adjust micafungin for obesity? Clinical outcome data is lacking but what's there seems mixed overall, nothing really conclusive. I don't think I've ever used or seen 200mg daily personally #IDSky #PharmSky
330
Julian Ventres, PharmD BCPS @jjventres.bsky.social · 12/12/2024
As if 6 months wasn't good enough. Lenacapavir is already poised to be a game-changer in HIV PrEP, but once yearly?! I can't imagine how much this will improve access
040
Julian Ventres, PharmD BCPS @jjventres.bsky.social · 12/12/2024
How much is everyone using single dose aminoglycosides for cystitis? Just Enterobacterales? Or Pseudomonas as well? Good option to prevent admission for more resistant organisms? Always sucks admitting a stable patient solely due to resistance profile. #IDSky #PharmSky
550
Reposted by Julian Ventres, PharmD BCPS
Erin McCreary, PharmD @erinmccreary.bsky.social · 11/12/2024
we updated our metronidazole dosing across UPMC system over a year ago based on Sunish's prelim work and now the final evaluation is published! so proud of him!! #idsky #amssky #pharmsky #medsky www.sciencedirect.com/science/arti...
3374
Reposted by Julian Ventres, PharmD BCPS
NEJM.org @nejm.org · 10/12/2024
On this day in 1981, a landmark paper in NEJM described four patients with evidence of immunodeficiency associated with PJP pneumonia, disseminated CMV, and Kaposi sarcoma. The disease would come to be known as HIV/AIDS. Revisit the paper: nej.md/41iekKD #MedSky #IDSky
Published on This Day in 1981.  
Pneumocystis carinii Pneumonia and Mucosal Candidiasis in Previously Healthy Homosexual Men — Evidence of a New Acquired Cellular Immunodeficiency  

An illustration showing the reproductive cycle of human immunodeficiency virus type 1 (HIV-1) and sites of action of the major classes of antiretroviral medications.  

The NEJM identity sits at the bottom.
12474217
Julian Ventres, PharmD BCPS @jjventres.bsky.social · 05/12/2024
#IDSky community, what are you/what do you see being used routinely for community SSTI? Are you still seeing SMX/TMP + cephalexin? Having trouble convincing my colleagues on SMX/TMP monotherapy when MRSA and Streptococcal coverage is wanted
810
Reposted by Julian Ventres, PharmD BCPS
Erin McCreary, PharmD @erinmccreary.bsky.social · 29/11/2024
🆕 #Breakpoints Episode: Drs. @annegretemartson.bsky.social, Megan Wimmer, and Evan Clemens join me to discuss all things (Val)ganciclovir!!! #idsky #pharmsky #amssky @sidpharm.bsky.social 🎧 sidp.pinecast.co
3329
Reposted by Julian Ventres, PharmD BCPS
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 25/11/2024
Endocarditis therapy has long been based on opinions of eminent experts rather than high-quality evidence 🔥PUBLISHED🔥 Our editorial with Dr.Spellberg✨️ @dremilymcd.bsky.social @drtoddlee.bsky.social Endocarditis Therapy: The Move From Expert Opinion to Evidence www.sciencedirect.com/science/arti...
65216
Julian Ventres, PharmD BCPS @jjventres.bsky.social · 25/11/2024
Really shows that resistance isn't just about usage; mechanism and evolutionary/fitness costs play a huge part as well #idsky
071
Reposted by Julian Ventres, PharmD BCPS
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 25/11/2024
Oral cephalosporins for pyelonephritis?! 🆕️⚡️⚡️COPY-ED Multicenter, retrospective study N=851 No difference in 14-day pyelonephritis treatment failure for oral cephalosporins* vs FQ/TMP-SMX for outpatient pyelonephritis in the ED #idsky #medsky * Mostly cephalexin www.sciencedirect.com/science/arti...
23314
Reposted by Julian Ventres, PharmD BCPS
Stanford Antimicrobial Safety & Sustainability Program @stanfordasp.bsky.social · 22/11/2024
🌟 ABX Pearl of the Day: Duration of treatment in intra-abdominal infections (IAI)! 💊 💡 Q: How long should I treat IAI after source control? 🔍 A: While STOP-IT trial calls for 4 days post-source control, there are notable exceptions. See infographic for details 👇 #IDsky #AMSsky #MedSky #Pharmsky
ABX durations for secondary peritonitis and acute cholecystitis and cholangitis
54424
Reposted by Julian Ventres, PharmD BCPS
Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · 21/11/2024
What did I do this morning? Fill out quick surveys about CDI! They’re quick and support very important research! #IDSky redcap.link/guubtkxs @connorprosty.bsky.social @drtoddlee.bsky.social @dremilymcd.bsky.social
redcap.mchi.mcgill.ca
Prophylaxis, Diagnosis, and Management of Clostridioides difficile Infections: An International Cross-Sectional Survey of Clinicians
263
Reposted by Julian Ventres, PharmD BCPS
Josh Davis @gurujosh.bsky.social · 21/11/2024
Hi #IDSky! I’m putting together my usual top 10 ID papers of this year list again (this time will post here not in the other world). Please tell me your candidate papers - practice changing paradigm shifting or dogma challenging!
209117
Reposted by Julian Ventres, PharmD BCPS
Erin McCreary, PharmD @erinmccreary.bsky.social · 18/11/2024
happy #antibioticawarenessweek!🦠 sharing a paper I ❤️ from Dr. Dinh, a lovely human who told me they noticed in their RCTs that some patients were getting exclusive PO treatment for CAP (dealers choice!) They explored these pts and its worth a read #idsky #pharmsky pubmed.ncbi.nlm.nih.gov/38734138/
pubmed.ncbi.nlm.nih.gov
Exclusive oral antibiotic treatment for hospitalized community-acquired pneumonia: a post-hoc analysis of a randomized clinical trial - PubMed
This trial is registered with ClinicalTrials.gov, NCT01963442.
1349
Reposted by Julian Ventres, PharmD BCPS
Ken Koon Wong @kenkoonwong.bsky.social · 15/11/2024
IDSKy This is one way of creating an anonymous poll using poll.blue @sebpoule.bsky.social @kartikacharyaid.bsky.social
kenkoonwong.com
🦋 Poll Tutorial For #IDSky | Everyday Is A School Day
A modern, beautiful, and easily configurable blog theme for Hugo.
3103
Reposted by Julian Ventres, PharmD BCPS
Carolyn Barber, MD @cbarbermd.bsky.social · 15/11/2024
Vaccines do work… #MedTwitter #MedSky #IDSky #MedEd  🧪 #EMSky #EMedSky
27525
Reposted by Julian Ventres, PharmD BCPS
Carrie Freed, Pharm.D., BCIDP, AAHIVP @apothecarrie.bsky.social · 14/11/2024
Back to the basics 😄✍️ #IDSky
2292
Reposted by Julian Ventres, PharmD BCPS
Bug Pharmacist // Tim Gauthier @idstewardship.bsky.social · 12/11/2024
Interesting! SubQ meropenem. “Subcutaneous meropenem appears to be well tolerated and has a favourable pharmacokinetic profile. Either 1.5 g twice daily or 3 g as a 24 h subcutaneous infusion could be considered for future evaluation.” academic.oup.com/jac/advance-...
academic.oup.com
Safety, tolerability and pharmacokinetics of subcutaneous meropenem as an alternative to intravenous administration
AbstractBackground. Subcutaneous delivery of antibiotics is a practical alternative to IV administration. Meropenem is commonly used to treat infections ca
83311
Reposted by Julian Ventres, PharmD BCPS
Dr Neil Stone @drneilstone.bsky.social · 12/11/2024
First paper to share here Delightful to have been part of the all new UK guidelines on the diagnosis of and management of eosinophilia! www.journalofinfection.com/article/S016...
journalofinfection.com
UK guidelines for the investigation and management of eosinophilia in returning travellers and migrants
Eosinophilia is a common finding in returning travellers, migrants and other travelling groups. In this setting it often indicates an underlying helminth infection. Infections associated with eosinoph...
910028
Reposted by Julian Ventres, PharmD BCPS
Katie Cinnamon, PharmD, BCPS, BCIDP @katiecinnamon.bsky.social · 12/11/2024
Interested in SIDP’s Antimicrobial Stewardship Certificate Program? To see the program description and to register, please visit buff.ly/3NXfAKW' #IDSky #MedSky @sidpharm.bsky.social
22110
Reposted by Julian Ventres, PharmD BCPS
dave @davembmd.bsky.social · 11/11/2024
Just to be very clear about things that work.
11547187
Reposted by Julian Ventres, PharmD BCPS
Daniela Barillà @danielabarilla.bsky.social · 10/11/2024
Can colleagues amplify this appeal to journals and journal editors to open accounts on Bluesky, please? @MicrobioSoc @TrendsMicrobiol @CellCellPress @JBacteriology @jbiolchem @Nature @ScienceMagazine @PNASNews @MolMicroEditors @NAR_Open @NatureMicrobiol @NatureComms @ASMicrobiology 🙏 🦠🧪🧫🧬
18271209
Reposted by Julian Ventres, PharmD BCPS
Ilan Schwartz @germhuntermd.bsky.social · 10/11/2024
IDSky continues to grow rapidly We are now >300 users, which means we are on a third Starter Pack IDSky Starter Pack 1 go.bsky.app/LnAQjdq IDSky Starter Pack 2 go.bsky.app/JNfSvQT ID Starter Pack 3 go.bsky.app/FeogT7o Check back on the most recent one often as it is updated frequently
#IDSky Starter Pack heading with 7 photos of users IDSky Starter Pack 2 heading IDSky Starter Pack 3 header
3620583
Julian Ventres, PharmD BCPS @jjventres.bsky.social · 10/11/2024
Is there really any role for clindamycin left? Linezolid just seems to be better for the few niches clinda had left. Oral, anti-toxin, and is better in regards to dosing, CDI, and resistance rates. Is there anything you'd still prefer clinda for? #IDSky #MedSky #PharmSky
9303
Reposted by Julian Ventres, PharmD BCPS
Ryan Marino, MD @ryanmarino.bsky.social · 08/11/2024
Toxicologist here for any fluoride concerns! The amount of fluoride added to water to prevent tooth decay is so minuscule that—no matter your age, size, or health status—you would die from water poisoning long before you could ever even start getting toxicity from fluoride. Fluoridated water is safe
360108682580
Reposted by Julian Ventres, PharmD BCPS
Ilan Schwartz @germhuntermd.bsky.social · 08/11/2024
Good news: Our community is growing! The IDSky Starter Pack has exceeded the max 150 accounts, so I’ve started on another (pls share here and the other place, and LMK if I missed you) IDSky starter pack 1 go.bsky.app/LnAQjdq IDSky starter pack 2 go.bsky.app/JNfSvQT
media.tenor.com
a man in a white shirt is standing in a corn field at sunset .
Alt: Kevin Costner from field of dreams is standing in a corn field at sunset . Text says “if you build it, they will come”
3018576
Reposted by Julian Ventres, PharmD BCPS
Andy Webb @ajwpharm.bsky.social · 08/11/2024
Along the lines of what others have started, here's a #SkyRx starter pack - if I'm missing you let me know! go.bsky.app/DTkEEWG
132312
Reposted by Julian Ventres, PharmD BCPS
Zack (Snacks) Nelson, PharmD, MPH @zacrobid.bsky.social · 08/11/2024
My first #IDSky post will be a shameless promotion of our new UTI WikiGuideline! jamanetwork.com/journals/jam... Of 37 questions, only 6 had enough data to fully meet criteria for a clear recommendation!
jamanetwork.com
Guidelines for the Prevention, Diagnosis, and Management of Urinary Tract Infections
This consensus statement creates a clinical guideline for the diagnosis and management of urinary tract infections that addresses the gap between the evidence and recommendation strength.
79027